Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Therapy with ribozyme to the proliferating cell nuclear antigen-ribozyme and 5-fluorouracil of experimental choroidal neovascularization in rats.

Kayikcioglu OR, Falkenstein I, Cheng L, Kozak I, La Bree L, Azen SP, Wong-Staal F, Paoni NF, Freeman WR.

J Ocul Pharmacol Ther. 2006 Feb;22(1):1-9.

PMID:
16503769
2.

Inhibitory effects of interferon-gamma on myocardial hypertrophy.

Jin H, Li W, Yang R, Ogasawara A, Lu H, Paoni NF.

Cytokine. 2005 Sep 21;31(6):405-14.

PMID:
16105741
3.

The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.

Suckow MA, Gutierrez LS, Risatti CA, Wolter WR, Taylor RE, Pollard M, Navari RM, Castellino FJ, Paoni NF.

Cancer Lett. 2004 Jun 25;209(2):165-9.

PMID:
15159018
4.

Thyrotropin-releasing hormone is induced in the left ventricle of rats with heart failure and can provide inotropic support to the failing heart.

Jin H, Fedorowicz G, Yang R, Ogasawara A, Peale F, Pham T, Paoni NF.

Circulation. 2004 May 11;109(18):2240-5. Epub 2004 Apr 19.

PMID:
15096458
5.

Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.

Paoni NF, Feldman MW, Gutierrez LS, Ploplis VA, Castellino FJ.

Physiol Genomics. 2003 Nov 11;15(3):228-35.

PMID:
13130079
6.

Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction.

Jin H, Yang R, Li W, Ogasawara AK, Schwall R, Eberhard DA, Zheng Z, Kahn D, Paoni NF.

J Pharmacol Exp Ther. 2003 Feb;304(2):654-60.

7.

Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice.

Paoni NF, Peale F, Wang F, Errett-Baroncini C, Steinmetz H, Toy K, Bai W, Williams PM, Bunting S, Gerritsen ME, Powell-Braxton L.

Physiol Genomics. 2002 Dec 3;11(3):263-72. Epub 2002 Dec 3.

PMID:
12399448
8.

Effects of early treatment with growth hormone on infarct size, survival, and cardiac gene expression after acute myocardial infarction.

Jin H, Yang R, Lu H, Ogasawara AK, Li W, Ryan A, Peale F, Paoni NF.

Growth Horm IGF Res. 2002 Aug;12(4):208-15.

PMID:
12175653
9.

Expression profiling techniques for cardiac molecular phenotyping.

Paoni NF, Lowe DG.

Trends Cardiovasc Med. 2001 Aug;11(6):218-21. Review.

PMID:
11673051
10.

Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction.

Jin H, Yang R, Awad TA, Wang F, Li W, Williams SP, Ogasawara A, Shimada B, Williams PM, de Feo G, Paoni NF.

Circulation. 2001 Feb 6;103(5):736-42.

PMID:
11156887
11.

Effects of exercise training on cardiac function, gene expression, and apoptosis in rats.

Jin H, Yang R, Li W, Lu H, Ryan AM, Ogasawara AK, Van Peborgh J, Paoni NF.

Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2994-3002.

12.

Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure.

Tajima M, Weinberg EO, Bartunek J, Jin H, Yang R, Paoni NF, Lorell BH.

Circulation. 1999 Jan 5-12;99(1):127-34.

PMID:
9884389
13.

Effects of cardiotrophin-1 on haemodynamics and cardiac function in conscious rats.

Jin H, Yang R, Ko A, Pennica D, Wood WI, Paoni NF.

Cytokine. 1998 Jan;10(1):19-25.

PMID:
9505141
14.

In vivo effects of cardiotrophin-1.

Jin H, Yang R, Keller GA, Ryan A, Ko A, Finkle D, Swanson TA, Li W, Pennica D, Wood WI, Paoni NF.

Cytokine. 1996 Dec;8(12):920-6.

PMID:
9050750
15.

Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo.

Lai J, Jin H, Yang R, Winer J, Li W, Yen R, King KL, Zeigler F, Ko A, Cheng J, Bunting S, Paoni NF.

Am J Physiol. 1996 Dec;271(6 Pt 2):H2197-208.

PMID:
8997275
16.

An experimental model of intracranial hemorrhage during thrombolytic therapy with t-PA.

Paoni NF, Steinmetz HG, Gillett N, Refino CJ, Badillo JM, Bunting S.

Thromb Haemost. 1996 May;75(5):820-6.

PMID:
8725730
17.
18.

New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA.

Benedict CR, Refino CJ, Keyt BA, Pakala R, Paoni NF, Thomas GR, Bennett WF.

Circulation. 1995 Nov 15;92(10):3032-40.

PMID:
7586274
19.

Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.

Jin H, Yang R, Gillett N, Clark RG, Ko A, Paoni NF.

J Cardiovasc Pharmacol. 1995 Sep;26(3):420-5.

PMID:
8583784
20.

Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex.

Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF, Wood WI.

J Biol Chem. 1995 May 5;270(18):10915-22.

21.

A faster-acting and more potent form of tissue plasminogen activator.

Keyt BA, Paoni NF, Refino CJ, Berleau L, Nguyen H, Chow A, Lai J, Peña L, Pater C, Ogez J, et al.

Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3670-4.

22.

A variant of t-PA (T103N, KHRR 296-299 AAAA) that, by bolus, has increased potency and decreased systemic activation of plasminogen.

Refino CJ, Paoni NF, Keyt BA, Pater CS, Badillo JM, Wurm FM, Ogez J, Bennett WF.

Thromb Haemost. 1993 Aug 2;70(2):313-9.

PMID:
8236141
23.

A slow clearing, fibrin-specific, PAI-1 resistant variant of t-PA (T103N, KHRR 296-299 AAAA).

Paoni NF, Keyt BA, Refino CJ, Chow AM, Nguyen HV, Berleau LT, Badillo J, Peña LC, Brady K, Wurm FM, et al.

Thromb Haemost. 1993 Aug 2;70(2):307-12.

PMID:
8236140
24.

Making tissue-type plasminogen activator more fibrin specific.

Paoni NF, Chow AM, Peña LC, Keyt BA, Zoller MJ, Bennett WF.

Protein Eng. 1993 Jul;6(5):529-34.

PMID:
8415579
25.

Involvement of residues 296-299 in the enzymatic activity of tissue-type plasminogen activator.

Paoni NF, Refino CJ, Brady K, Peña LC, Nguyen HV, Kerr EM, Johnson AC, Wurm FM, van Reis R, Botstein D, et al.

Protein Eng. 1992 Apr;5(3):259-66.

PMID:
1409547
26.

High resolution analysis of functional determinants on human tissue-type plasminogen activator.

Bennett WF, Paoni NF, Keyt BA, Botstein D, Jones AJ, Presta L, Wurm FM, Zoller MJ.

J Biol Chem. 1991 Mar 15;266(8):5191-201.

27.

Improved method for detection of glycosidases in bacterial colonies.

Paoni NF, Arroyo RL.

Appl Environ Microbiol. 1984 Jan;47(1):208-9.

28.

Permeabilization of cells for studies on the biochemistry of bacterial chemotaxis.

Paoni NF, Koshland DE Jr.

Proc Natl Acad Sci U S A. 1979 Aug;76(8):3693-7.

29.
30.

Isolation and characterization of native and lower molecular weight forms of sheep plasminogen.

Paoni NF, Violand BN, Castellino FJ.

J Biol Chem. 1977 Nov 10;252(21):7725-32.

31.

Isolation of a low molecular weight form of plasminogen.

Paoni NF, Castellino FJ.

Biochem Biophys Res Commun. 1975 Jul 22;65(2):757-64. No abstract available.

PMID:
125089

Supplemental Content

Loading ...
Support Center